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Purpose: One risk factor in osteoarthritis (OA) is obesity but little is known
about the interaction between bone formation and adipose tissue-derived
factors. Adipocytes produce many cytokine-like proteins, e.g. adiponectin,
visfatin or resistin. These adipokines can also be produced by other cell
types (ﬁbroblasts, osteoblasts, osteoclasts). While an association with the
pathogenesis of rheumatoid arthritis has already been shown, their role in
osteophyte formation in OA has not been studied yet. The mechanisms of
osteophyte formation are mostly unknown but there is growing evidence
that inﬂammation and local stress play a role in this process. In this study,
the expression of adipokines in osteophytes and their co-localization with
cells of bone remodeling was analyzed.
Methods: Osteophyte tissue and cartilage was obtained from OA patients
during joint replacement surgery. Using serial sections of osteophyte
tissue and hematoxylin/eosin and Masson trichrome staining, the osteo-
phytes were scored and divided into grade one to ﬁve (grade 1: no ossi-
ﬁcation, consinsting of connective tissue (CT) and cartilage ; grade 2: CT
and cartilage about 80%, max. 20% of ossiﬁed and mineralized areas; grade
3: the non-ossiﬁed osteophyte part consists of about 50% CT and 50%
cartilage, more than 20% of ossiﬁcation and mineralization of the osteo-
phyte; grade 4: ossiﬁed, mineralized osteophyte with cartilage, less than
10% CT, no ossiﬁed remodeling zones; grade 5: ossiﬁed, mineralized
osteophyte with cartilage, CT less than 10%, ossiﬁed remodeling zones). To
identify the localization of adipokines, immunohistochemistry was per-
formed against alkaline phosphatase, collagen type I and II, adiponectin,
visfatin, and resistin. TRAP stainings were performed for osteoclast iden-
tiﬁcation. Immunoassay analyses for visfatin were done with ground
cartilage and lysates of isolated chondrocytes.
Results: In all osteophyte grades of OA patients (1-5), adiponectin, visfatin
and resistin expression was detectable at different levels. In non-ossiﬁed
osteophytes, adiponectin was localized around blood vessels and in 25% to
50% of CT ﬁbroblasts. Resistin and visfatin were localized in single ﬁbro-
blasts within the connective tissue.
Reduced amounts of adiponectin were detectable in ossiﬁed and miner-
alized osteophytes in comparison to non-ossiﬁed osteophytes. In about
65% of the samples, a co-localization with osteoblasts was visible. Resistin
and visfatin showed a co-localization with osteoblasts and osteoclasts at
sites of bone remodeling in about 70% of the samples. Visfatin could be
detected in chondrocytes in ossiﬁed and non-ossiﬁed osteophytes, and its
expression could be conﬁrmed by ELISA using lysates of cartilage and
isolated chondrocytes.
Conclusions: The expression of visfatin in chondrocytes in the osteophyte
cartilage and adiponectin in osteophyte connective tissue suggests them to
be involved in early stages of osteophyte formation. The co-localization of
resistin and visfatin with osteoblasts and osteoclasts in ossiﬁed and miner-
alized osteophytes suggests an involvement in bone formation and remod-
eling of OA osteophytes in later stages. Therefore, adiponectin, resistin, and
visfatin are involved in osteophyte formation at different stages and affect
different cell types of cartilage and bone formation during these processes.
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SUBCHONDRAL BONE CHANGE AT OSTEOARTHRITIS ONSET -
A COMPARATIVE STUDY ON GUINEA PIGS WITH AND WITHOUT
OSTEOARTHRITIS
T. Wang. The Univ. of Hong Kong, Hong Kong, China
Purpose: Osteoarthritis (OA) is one of the most prevalent joint diseases. To
date, the pathogenesis and treatment of OA still remain to be elucidated.Recent research reported that subchondral bone plays an important role in
the pathogenesis of knee OA1. The objective of this study was to longitu-
dinally observe and characterize the subchondral bone at the very early
stage of OA before cartilage degeneration using Dunkin-Hartley (DH)
guinea pig spontaneous OA model with Micro-CT and histology, with
Bristol Strain 2 (S2) guinea pig as control.
Methods: Eighteen Dunkin-Hartley and eighteen Bristol Strain 2 guinea
pigs were divided into 3 groups (6 for each), and theywere sacriﬁced at 1, 2
and 3 months for histological evaluation of cartilage with OARSI score2
(H&E and Safranin O staining). The knee joints of 3-month group (n¼6)
were scanned withMicro-CTat age of 1, 2 and 3months to characterize the
subchondral bone of knee joints.
Results: Histological study revealed that the difference of OARSI score
between two groups were not signiﬁcant (Table 1). No signiﬁcant articular
cartilage degeneration was noted at the age of 3 month in both DH and S2
guinea pigs. Only focal hypercellularity in deep zone of articular cartilage
were observed in DH guinea pigs of 3 months old.
Micro-CT analysis revealed that both trabecular and cortical bone are
thicker in DH group guinea pigs than S2 strain. In addition, trabecular
morphology turns to be more plate-like and the organization became less
anisotropic in subchondral cancellous bone of DH guinea pig as compared
with S2 strain (Figure 1).
ĂConclusions: Subchondral bone change was deﬁned in DH guinea pig
spontaneous OA model in terms of over bone formation and trabecular
structure turnover at very early stage of OA initiation right before cartilage
damage. Further study may be conducted to explore the underlying
mechanism in the process of bone remodeling, which may provide new
insight to OA pathogenesis and potential treatment solutions.
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SR1078, A SYNTHETIC LIGAND OF NUCLEAR RECEPTOR ROR ALPHA,
MODULATES OSTEOBLAST METABOLISM WITH ANTI-INFLAMMATORY
EFFECTS
J. Fernandes, M. Benderdor, Q. Shi. Univ. of Montreal, Montreal, QC, Canada
Objective: To elucidate the effect of one synthetic ligand (SR1078) of
nuclear receptor retinoid-related orphan receptor alpha (ROR alpha) in
human MG-63 osteoblast-like cells.
Methods: SR1078 represents the ﬁrst synthetic ligand that is able to
function as an ROR agonist (Wang YJ et al., ACS Chemical Biology, Vol.5
